JP Morgan analyst Michael Rehaut maintains TopBuild (NYSE:BLD) with a Neutral and lowers the price target from $209 to $190.
Wells Fargo Maintains Overweight on Cerence, Lowers Price Target to $64
Wells Fargo analyst Colin Langan maintains Cerence (NASDAQ:CRNC) with a Overweight and lowers the price target from $66 to $64.